• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与潜在阿尔茨海默病和路易体病相关的轻度认知障碍。

Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease.

机构信息

Division of Behavioral Neurology, Department of Neurology, and Center for Sleep Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

出版信息

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S41-4. doi: 10.1016/S1353-8020(11)70015-3.

DOI:10.1016/S1353-8020(11)70015-3
PMID:22166451
Abstract

The objective of this paper is to compare and contrast the clinical, neuropsychological, and neuroimaging findings in patients with mild cognitive impairment (MCI) associated with underlying Alzheimer's disease (AD) versus Lewy body disease (LBD) pathology. MCI refers to a clinical syndrome with impairment in one or more cognitive domains, with essentially normal performance of activities of daily living. Patients with the amnesic subtype of MCI often develop the dementia syndrome and neuroimaging findings characteristic of AD [e.g., hippocampal atrophy on magnetic resonance imaging (MRI), temporoparietal and posterior cingulate hypometabolism on fluorodeoxyglucose positron emission tomography (FDG-PET), positive uptake on amyloid PET, normal striatonigral uptake on dopamine transporter scanning (DAT), etc.]. In contrast, the MCI syndrome associated with LBD pathology regardless of the coexisting presence or absence of parkinsonism is usually characterized by impairment in the executive and/or visuospatial domains, and the cognitive features are often preceded by REM sleep behavior disorder by many years. There is minimal hippocampal atrophy on MRI, minimal if any cortical uptake on amyloid-PET, and one would predict that hypometabolism would be maximal in the occipital cortex on FDG-PET and uptake would be decreased on DAT. The early data suggests that differentiating underlying AD vs LBD in the MCI phase will be feasible.

摘要

本文旨在比较和对比伴有潜在阿尔茨海默病(AD)与路易体病(LBD)病理学的轻度认知障碍(MCI)患者的临床、神经心理学和神经影像学表现。MCI 是指一种临床综合征,存在一个或多个认知领域的损害,日常生活活动的表现基本正常。遗忘型 MCI 患者常发展为痴呆综合征和 AD 的神经影像学表现[例如,磁共振成像(MRI)上的海马萎缩,氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)上的颞顶和后扣带回代谢低下,淀粉样 PET 上的阳性摄取,多巴胺转运蛋白扫描(DAT)上的纹状体摄取正常等]。相比之下,无论是否伴有帕金森病,与 LBD 病理学相关的 MCI 综合征通常以执行和/或视空间领域的损害为特征,认知特征通常在 REM 睡眠行为障碍多年前就出现了。MRI 上的海马萎缩最小,如果有的话,皮质上的淀粉样蛋白摄取也最小,人们预计 FDG-PET 上的枕叶皮层代谢低下最大,DAT 上的摄取减少。早期数据表明,在 MCI 阶段区分潜在的 AD 与 LBD 是可行的。

相似文献

1
Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease.与潜在阿尔茨海默病和路易体病相关的轻度认知障碍。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S41-4. doi: 10.1016/S1353-8020(11)70015-3.
2
Clinical and multimodal biomarker correlates of ADNI neuropathological findings.ADNI 神经病理学发现的临床和多模态生物标志物相关性。
Acta Neuropathol Commun. 2013 Oct 9;1:65. doi: 10.1186/2051-5960-1-65.
3
Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.轻度认知障碍倾向于转化为阿尔茨海默病或路易体痴呆的特征:一项记忆门诊的随访研究。
J Neurol Sci. 2016 Oct 15;369:102-108. doi: 10.1016/j.jns.2016.08.011. Epub 2016 Aug 4.
4
Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.路易体病和阿尔茨海默病对脑萎缩和认知功能障碍的影响。
Neurology. 2019 Apr 23;92(17):e2015-e2026. doi: 10.1212/WNL.0000000000007373. Epub 2019 Apr 3.
5
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.淀粉样蛋白、代谢低下和萎缩对神经心理学功能的长期影响。
Neurology. 2014 May 20;82(20):1768-75. doi: 10.1212/WNL.0000000000000432. Epub 2014 Apr 18.
6
Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.在一个早期富集的轻度认知障碍样本中,用于预测转化和认知衰退的认知标志物和生物标志物的不同强度。
J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.
7
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.阿尔茨海默病成像生物标志物的比较:使用[18F]氟比他哌正电子发射断层扫描进行淀粉样蛋白成像以及对内嗅皮质萎缩进行基于磁共振成像体素的分析。
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
8
Symptoms associated with Lewy body disease in mild cognitive impairment.路易体病相关轻度认知障碍的症状。
Int J Geriatr Psychiatry. 2017 Nov;32(11):1163-1171. doi: 10.1002/gps.4742. Epub 2017 May 29.
9
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.轻度认知障碍患者路易体病的神经影像学表现和临床轨迹。
Neurobiol Aging. 2019 Apr;76:9-17. doi: 10.1016/j.neurobiolaging.2018.12.001. Epub 2018 Dec 13.
10
Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.三名老年前期患者,其神经心理学和神经影像学检查提示可能进展为路易体痴呆。
Psychogeriatrics. 2014 Mar;14(1):72-80. doi: 10.1111/psyg.12039. Epub 2014 Feb 16.

引用本文的文献

1
Electroencephalographic slowing during REM sleep in older adults with subjective cognitive impairment and mild cognitive impairment.老年人主观认知障碍和轻度认知障碍 REM 睡眠时脑电图减慢。
Sleep. 2024 Jun 13;47(6). doi: 10.1093/sleep/zsae051.
2
Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.路易体痴呆的轻度认知障碍:更新与展望。
J Neural Transm (Vienna). 2023 Dec;130(12):1491-1508. doi: 10.1007/s00702-023-02670-1. Epub 2023 Jul 7.
3
A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment.
一项针对遗忘型轻度认知障碍患者视网膜血管损伤的两年纵向研究。
Front Aging Neurosci. 2022 Nov 7;14:993621. doi: 10.3389/fnagi.2022.993621. eCollection 2022.
4
Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective Study.轻度认知障碍人群中,随着认知能力下降,血液 D-氨基酸氧化酶水平升高:一项为期两年的前瞻性研究。
Int J Neuropsychopharmacol. 2022 Aug 16;25(8):660-665. doi: 10.1093/ijnp/pyac027.
5
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study.轻度认知障碍(MCI)患者血浆谷胱甘肽水平随认知功能下降而降低:一项为期两年的前瞻性研究。
Antioxidants (Basel). 2021 Nov 19;10(11):1839. doi: 10.3390/antiox10111839.
6
FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.FDG PET 代谢特征可区分前驱期 DLB 和前驱期 AD。
Neuroimage Clin. 2021;31:102754. doi: 10.1016/j.nicl.2021.102754. Epub 2021 Jul 4.
7
Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial.苯甲酸盐(一种 D-氨基酸氧化酶抑制剂)对轻度认知障碍患者的脑活动影响:一项随机、双盲、安慰剂对照的临床试验。
Int J Neuropsychopharmacol. 2021 May 18;24(5):392-399. doi: 10.1093/ijnp/pyab001.
8
Berberine ameliorates rats model of combined Alzheimer's disease and type 2 diabetes mellitus via the suppression of endoplasmic reticulum stress.黄连素通过抑制内质网应激改善阿尔茨海默病合并2型糖尿病大鼠模型。
3 Biotech. 2020 Aug;10(8):359. doi: 10.1007/s13205-020-02354-7. Epub 2020 Jul 29.
9
Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β via activating the BDNF/TrkB signal pathway.多奈哌齐通过激活 BDNF/TrkB 信号通路改善阿尔茨海默病淀粉样β诱导的树鼩认知功能障碍。
Metab Brain Dis. 2018 Dec;33(6):1961-1974. doi: 10.1007/s11011-018-0303-6. Epub 2018 Aug 13.
10
Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients.淀粉样蛋白阳性与淀粉样蛋白阴性遗忘型轻度认知障碍患者的神经心理学和神经影像学特征
Alzheimers Dement (Amst). 2018 Mar 17;10:269-277. doi: 10.1016/j.dadm.2018.02.008. eCollection 2018.